期刊文献+

Serum magnesium concentration in children with functional constipation treated with magnesium oxide 被引量:4

Serum magnesium concentration in children with functional constipation treated with magnesium oxide
下载PDF
导出
摘要 AIM:To determine whether hypermagnesemia recently reported in adult patients possibly develops in children with functional constipation taking daily magnesium oxide.METHODS:We enrolled 120 patients (57 male and 63 female) aged 1-14 years old (median:4.7 years) with functional constipation from 13 hospitals and two private clinics.All patients fulfilled the Rome Ⅲ criteria for functional constipation and were treated with daily oral magnesium oxide for at least 1 mo.The median treatment dose was 600 (500-800) mg/d.Patients were assessed by an interview and laboratory examination to determine possible hypermagnesemia.Serum magnesium concentration was also measured in sex-and agematched control subjects (n=38).RESULTS:In the constipation group,serum magnesium concentration [2.4 (2.3-2.5) mg/dL,median and interquartile range] was significantly greater than that of the control group [2.2 (2.0-2.2) mg/dL] (P < 0.001).The highest value was 3.2 mg/dL.Renal magnesium clearance was significantly increased in the constipation group.Serum magnesium concentration in the constipation group decreased significantly with age (P < 0.01).There was no significant correlation between the serum level of magnesium and the duration of treatment with magnesium oxide or the daily dose.None of the patients had side effects associated with hypermagnesemia.CONCLUSION:Serum magnesium concentration increased significantly,but not critically,after daily treatment with magnesium oxide in constipated children with normal renal function. AIM:To determine whether hypermagnesemia recently reported in adult patients possibly develops in children with functional constipation taking daily magnesium oxide.METHODS:We enrolled 120 patients (57 male and 63 female) aged 1-14 years old (median:4.7 years) with functional constipation from 13 hospitals and two private clinics.All patients fulfilled the Rome Ⅲ criteria for functional constipation and were treated with daily oral magnesium oxide for at least 1 mo.The median treatment dose was 600 (500-800) mg/d.Patients were assessed by an interview and laboratory examination to determine possible hypermagnesemia.Serum magnesium concentration was also measured in sex-and agematched control subjects (n=38).RESULTS:In the constipation group,serum magnesium concentration [2.4 (2.3-2.5) mg/dL,median and interquartile range] was significantly greater than that of the control group [2.2 (2.0-2.2) mg/dL] (P 0.001).The highest value was 3.2 mg/dL.Renal magnesium clearance was significantly increased in the constipation group.Serum magnesium concentration in the constipation group decreased significantly with age (P 0.01).There was no significant correlation between the serum level of magnesium and the duration of treatment with magnesium oxide or the daily dose.None of the patients had side effects associated with hypermagnesemia.CONCLUSION:Serum magnesium concentration increased significantly,but not critically,after daily treatment with magnesium oxide in constipated children with normal renal function.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第6期779-783,共5页 世界胃肠病学杂志(英文版)
关键词 CHILDREN CONSTIPATION HYPERMAGNESEMIA Magnesium oxide Renal dysfunction 治疗剂量 氧化镁 便秘 血清 浓度 实验室检查 中位数 记者采访
  • 引文网络
  • 相关文献

参考文献24

  • 1Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006; 43:e1-e13. 被引量:1
  • 2Benninga MA, Voskuijl WP, Taminiau JA. Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004; 39:448464. 被引量:1
  • 3Felt B, Wise CG, Olson A, Kochhar P, Marcus S, Coran A. Guideline for the management of pediatric idiopathic consti- pation and soiling. Multidisciplinary team from the University of Michigan Medical Center in Ann Arbor. Arch Pediatr Adolesc Med 1999; 153:380-385. 被引量:1
  • 4http://www.info.pmda.go.jp/iyaku_anzen/file/PMDSI252. pdf. 被引量:1
  • 5Van Hook JW. Endocrine crises. Hypermagnesemia. Crit Care Clin 1991; 7:215-223. 被引量:1
  • 6Clark BA, Brown RS. Unsuspected morbid hypermagnese- mia in elderly patients. AmJ Neph.ro11992, 12:336-343. 被引量:1
  • 7Morisaki H, Yamamoto S, Morita Y, Kotake Y, Ochiai R, Takeda J. Hypermagnesemia-induced cardiopulmonary ar- rest before induction of anesthesia for emergency cesarean section. J Clin Anesth 2000; 12:224-226. 被引量:1
  • 8Vissers RJ, Purssell R. Iatrogenic magnesium overdose: two case reports. J Emerg Med 1996; 14:187-191. 被引量:1
  • 9Schelling JR. Fatal hypermagnesemia. Clin Nephrol 2000; 53: 61-65. 被引量:1
  • 10McLaughlin SA, McKinney PE. Antacid-induced hyperma- gnesemia in a patient with normal renal function and bowel obstruction. Ann Pharmacother 1998; 32:312-315. 被引量:1

同被引文献29

引证文献4

二级引证文献26

;
使用帮助 返回顶部